Table 1.
Head and neck pathologies of hospitalized patients before and during the COVID-19 pandemic
| DISEASES | Pre-COVID-19 Timea |
COVID-19 Timeb |
Percentage decrease (%) |
|---|---|---|---|
| Adenoid hypertrophy/adenotonsillar hypertrophy | 108 | 4 | −96.3% |
| Airways obstruction (dyspnea) | 63 | 53 | −15.9% |
| Benign tumors of head and neck | 64 | 39 | −39.1% |
| Congenital cysts and fistulas of the neck | 4 | 0 | −100% |
| Diseases of the paranasal sinuses and tympanomastoid cavity requiring surgery | 116 | 32 | −72.4% |
| Dentofacial deformity | 66 | 31 | −53.0% |
| Epistaxis | 16 | 8 | −50.0% |
| Pharyngotonsillitis/ peritonsillar abscess | 23 | 11 | − 52.2% |
| Malignant neoplasms of the head and neck | 58 | 56 | −3.7% |
| Maxillofacial trauma | 71 | 38 | −46.5% |
| Miscellanea | 373 | 170 | −54.4% |
| Nasal bone fractures | 36 | 12 | − 66.7% |
| Nasal deformities/septal deviation | 33 | 0 | −100% |
| Otitis media | 27 | 7 | −74.1% |
|
Otitis media with effusion (ear tube insertion) |
17 | 0 | −100% |
| Vertigo | 45 | 8 | −82.2% |
aPre-COVID-19 Time: March 1st to November 30th, 2019
bCOVID-19 Time: March 1st to November 30th, 2020